“Global Medical Device Contract Manufacturing market set to grow to $115bn by 2022” says Visiongain pharma consultant

19 July 2018
Pharma

Visiongain’ has launched a new pharma report Medical Device Contract Manufacturing Market Report: Electronic Manufacturing Services, Materials Processing, Finished Products, Medical Diagnostic Devices, Monitoring & Surgical Equipments, Therapeutic Devices.

The global medical device industry is a large, intensely competitive and highly innovative market. The US accounts for the largest share of the market. The industry may be subdivided into various segments based on the therapeutic area that a medical device is aimed at. These include medical devices in sectors such as cardiology, orthopaedic, and wound care among others.

The medical device industry has witnessed significant growth during the past decade, owing to new product launches, an ageing population and geographic expansion. As most of the prominent companies in the industry operate globally, the growth of the industry is highly dependent on the economic conditions prevailing in the international market.

The lead analyst of the report commented “In-house manufacturing of electronic parts by medical device OEMs would require heavy capital investment to produce. The expanding technology and capabilities offered by contract manufacturers has been a major factor in the growth of this market. Medical device companies are facing increased competition coupled with pressures to cut costs and improve the quality of their products. This has coincided with EMS providers improving their capabilities and expertise by offering OEMs a broader array of manufacturing location and services.”

Leading companies featured in the report include Benchmark Electronics, Flextronics, Forefront Medical Technology, Greatbatch, Jabil Circuit, Nortech Systems, TE Connectivity (Creganna Medical), Tecomet (Symmetry Medical), The Tech Group (West Pharmaceutical Services), Vention Medical.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever